Global Cyclooxygenase 2 Inhibitor Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 05-Dec-2022
No. of pages: 111
Inquire Before Buying

COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has extremely low activity in normal tissue cells, and can only be produced in large quantities when induced. It mediates pain, inflammation, and fever by promoting PG synthesis. In general, multiple adverse effects of non-steroidal anti-inflammatory drugs are believed to be related to the inhibition of COX-1. As a result, COX-2 selective inhibitors have emerged.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cyclooxygenase 2 Inhibitor estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Cyclooxygenase 2 Inhibitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Cyclooxygenase 2 Inhibitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Cyclooxygenase 2 Inhibitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Cyclooxygenase 2 Inhibitor include Pfizer, Bayer, Novartis, Merck, Sabinsa, Cadila Pharmaceuticals, Mylan, Teva Pharmaceutical and Alembic Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cyclooxygenase 2 Inhibitor companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Cyclooxygenase 2 Inhibitor market. Further, it explains the major drivers and regional dynamics of the global Cyclooxygenase 2 Inhibitor market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Pfizer

- Bayer

- Novartis

- Merck

- Sabinsa

- Cadila Pharmaceuticals

- Mylan

- Teva Pharmaceutical

- Alembic Pharmaceutical

- Aurobindo Pharma

- Cipla

- Torrent Pharmaceuticals

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Cyclooxygenase 2 Inhibitor Segment by Type

- Selective Cox 2 Inhibitor

- Non-Selective Cox 2 Inhibitor

Cyclooxygenase 2 Inhibitor Segment by Application

- Hospital

- Specialty Clinic

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Cyclooxygenase 2 Inhibitor market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Cyclooxygenase 2 Inhibitor market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Cyclooxygenase 2 Inhibitor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cyclooxygenase 2 Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cyclooxygenase 2 Inhibitor revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cyclooxygenase 2 Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cyclooxygenase 2 Inhibitor revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, Bayer, Novartis, Merck, Sabinsa, Cadila Pharmaceuticals, Mylan, Teva Pharmaceutical and Alembic Pharmaceutical, etc.

Global Cyclooxygenase 2 Inhibitor Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Selective Cox 2 Inhibitor
1.2.3 Non-Selective Cox 2 Inhibitor
1.3 Market by Application
1.3.1 Global Cyclooxygenase 2 Inhibitor Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Cyclooxygenase 2 Inhibitor Market Size (2017-2028)
2.2 Cyclooxygenase 2 Inhibitor Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Cyclooxygenase 2 Inhibitor Market Size by Region (2017-2022)
2.4 Global Cyclooxygenase 2 Inhibitor Market Size Forecast by Region (2023-2028)
2.5 Global Top Cyclooxygenase 2 Inhibitor Countries Ranking by Market Size
3 Cyclooxygenase 2 Inhibitor Competitive by Company
3.1 Global Cyclooxygenase 2 Inhibitor Revenue by Players
3.1.1 Global Cyclooxygenase 2 Inhibitor Revenue by Players (2017-2022)
3.1.2 Global Cyclooxygenase 2 Inhibitor Market Share by Players (2017-2022)
3.2 Global Cyclooxygenase 2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Cyclooxygenase 2 Inhibitor Revenue
3.4 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio
3.4.1 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclooxygenase 2 Inhibitor Revenue in 2021
3.5 Global Cyclooxygenase 2 Inhibitor Key Players Head office and Area Served
3.6 Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
3.7 Date of Enter into Cyclooxygenase 2 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Cyclooxygenase 2 Inhibitor Breakdown Data by Type
4.1 Global Cyclooxygenase 2 Inhibitor Historic Revenue by Type (2017-2022)
4.2 Global Cyclooxygenase 2 Inhibitor Forecasted Revenue by Type (2023-2028)
5 Global Cyclooxygenase 2 Inhibitor Breakdown Data by Application
5.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Application (2017-2022)
5.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022)
6.2 North America Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2028)
6.3 North America Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2028)
6.4 North America Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022)
7.2 Europe Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2028)
7.3 Europe Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2028)
7.4 Europe Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022)
8.2 Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2028)
8.3 Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2028)
8.4 Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022)
9.2 Latin America Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2028)
9.3 Latin America Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2028)
9.4 Latin America Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022)
10.2 Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2028)
10.3 Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2028)
10.4 Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Products and Services
11.1.4 Pfizer Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.1.5 Pfizer Cyclooxygenase 2 Inhibitor SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Cyclooxygenase 2 Inhibitor Products and Services
11.2.4 Bayer Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.2.5 Bayer Cyclooxygenase 2 Inhibitor SWOT Analysis
11.2.6 Bayer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Cyclooxygenase 2 Inhibitor Products and Services
11.3.4 Novartis Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.3.5 Novartis Cyclooxygenase 2 Inhibitor SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Cyclooxygenase 2 Inhibitor Products and Services
11.4.4 Merck Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.4.5 Merck Cyclooxygenase 2 Inhibitor SWOT Analysis
11.4.6 Merck Recent Developments
11.5 Sabinsa
11.5.1 Sabinsa Company Details
11.5.2 Sabinsa Business Overview
11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Products and Services
11.5.4 Sabinsa Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.5.5 Sabinsa Cyclooxygenase 2 Inhibitor SWOT Analysis
11.5.6 Sabinsa Recent Developments
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Company Details
11.6.2 Cadila Pharmaceuticals Business Overview
11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Products and Services
11.6.4 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.6.5 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor SWOT Analysis
11.6.6 Cadila Pharmaceuticals Recent Developments
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Cyclooxygenase 2 Inhibitor Products and Services
11.7.4 Mylan Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.7.5 Mylan Cyclooxygenase 2 Inhibitor SWOT Analysis
11.7.6 Mylan Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Products and Services
11.8.4 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.8.5 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor SWOT Analysis
11.8.6 Teva Pharmaceutical Recent Developments
11.9 Alembic Pharmaceutical
11.9.1 Alembic Pharmaceutical Company Details
11.9.2 Alembic Pharmaceutical Business Overview
11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Products and Services
11.9.4 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.9.5 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor SWOT Analysis
11.9.6 Alembic Pharmaceutical Recent Developments
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Products and Services
11.10.4 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.10.5 Aurobindo Pharma Cyclooxygenase 2 Inhibitor SWOT Analysis
11.10.6 Aurobindo Pharma Recent Developments
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Cyclooxygenase 2 Inhibitor Products and Services
11.11.4 Cipla Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.11.5 Cipla Recent Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Details
11.12.2 Torrent Pharmaceuticals Business Overview
11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Products and Services
11.12.4 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.12.5 Torrent Pharmaceuticals Recent Developments
12 Cyclooxygenase 2 Inhibitor Market Dynamics
12.1 Cyclooxygenase 2 Inhibitor Market Trends
12.2 Cyclooxygenase 2 Inhibitor Market Drivers
12.3 Cyclooxygenase 2 Inhibitor Market Challenges
12.4 Cyclooxygenase 2 Inhibitor Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Selective Cox 2 Inhibitor
Table 3. Key Players of Non-Selective Cox 2 Inhibitor
Table 4. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Cyclooxygenase 2 Inhibitor Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Region (2017-2022)
Table 8. Global Cyclooxygenase 2 Inhibitor Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Cyclooxygenase 2 Inhibitor Market Share by Players (2017-2022)
Table 10. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2021)
Table 11. Ranking of Global Top Cyclooxygenase 2 Inhibitor Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Cyclooxygenase 2 Inhibitor Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Cyclooxygenase 2 Inhibitor Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2022)
Table 19. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2023-2028)
Table 21. Global Cyclooxygenase 2 Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2022)
Table 23. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2023-2028)
Table 25. North America Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Cyclooxygenase 2 Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Cyclooxygenase 2 Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Cyclooxygenase 2 Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Cyclooxygenase 2 Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Cyclooxygenase 2 Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Cyclooxygenase 2 Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Cyclooxygenase 2 Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Cyclooxygenase 2 Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Cyclooxygenase 2 Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue by Country (2023-2028) & (US$ Million)
Table 60. Pfizer Company Details
Table 61. Pfizer Business Overview
Table 62. Pfizer Cyclooxygenase 2 Inhibitor Product and Services
Table 63. Pfizer Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 64. Pfizer Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 65. Pfizer Recent Developments
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Cyclooxygenase 2 Inhibitor Product and Services
Table 69. Bayer Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 70. Bayer Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 71. Bayer Recent Developments
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Cyclooxygenase 2 Inhibitor Product and Services
Table 75. Novartis Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 76. Novartis Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 77. Novartis Recent Developments
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Cyclooxygenase 2 Inhibitor Product and Services
Table 81. Merck Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 82. Merck Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 83. Merck Recent Developments
Table 84. Sabinsa Company Details
Table 85. Sabinsa Business Overview
Table 86. Sabinsa Cyclooxygenase 2 Inhibitor Product and Services
Table 87. Sabinsa Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 88. Sabinsa Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 89. Sabinsa Recent Developments
Table 90. Cadila Pharmaceuticals Company Details
Table 91. Cadila Pharmaceuticals Business Overview
Table 92. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product and Services
Table 93. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 94. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 95. Cadila Pharmaceuticals Recent Developments
Table 96. Mylan Company Details
Table 97. Mylan Business Overview
Table 98. Mylan Cyclooxygenase 2 Inhibitor Product and Services
Table 99. Mylan Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 100. Mylan Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 101. Mylan Recent Developments
Table 102. Teva Pharmaceutical Company Details
Table 103. Teva Pharmaceutical Business Overview
Table 104. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product and Services
Table 105. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 106. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 107. Teva Pharmaceutical Recent Developments
Table 108. Alembic Pharmaceutical Company Details
Table 109. Alembic Pharmaceutical Business Overview
Table 110. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product and Services
Table 111. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 112. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 113. Alembic Pharmaceutical Recent Developments
Table 114. Aurobindo Pharma Company Details
Table 115. Aurobindo Pharma Business Overview
Table 116. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product and Services
Table 117. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 118. Aurobindo Pharma Cyclooxygenase 2 Inhibitor SWOT Analysis
Table 119. Aurobindo Pharma Recent Developments
Table 120. Cipla Company Details
Table 121. Cipla Business Overview
Table 122. Cipla Cyclooxygenase 2 Inhibitor Product and Services
Table 123. Cipla Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 124. Cipla Recent Developments
Table 125. Torrent Pharmaceuticals Company Details
Table 126. Torrent Pharmaceuticals Business Overview
Table 127. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product and Services
Table 128. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 129. Torrent Pharmaceuticals Recent Developments
Table 130. Cyclooxygenase 2 Inhibitor Market Trends
Table 131. Cyclooxygenase 2 Inhibitor Market Drivers
Table 132. Cyclooxygenase 2 Inhibitor Market Challenges
Table 133. Cyclooxygenase 2 Inhibitor Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclooxygenase 2 Inhibitor Sales Market Share by Type: 2021 VS 2028
Figure 2. Selective Cox 2 Inhibitor Features
Figure 3. Non-Selective Cox 2 Inhibitor Features
Figure 4. Global Cyclooxygenase 2 Inhibitor Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Cyclooxygenase 2 Inhibitor Report Years Considered
Figure 9. Global Cyclooxygenase 2 Inhibitor Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cyclooxygenase 2 Inhibitor Market Size 2017-2028 (US$ Million)
Figure 11. Global Cyclooxygenase 2 Inhibitor Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Cyclooxygenase 2 Inhibitor Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Cyclooxygenase 2 Inhibitor Market Share by Players in 2021
Figure 15. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2021
Figure 17. North America Cyclooxygenase 2 Inhibitor Revenue Market Share by Company in 2021
Figure 18. North America Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2028)
Figure 19. North America Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2028)
Figure 20. North America Cyclooxygenase 2 Inhibitor Revenue Share by Country (2017-2028)
Figure 21. U.S. Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Cyclooxygenase 2 Inhibitor Revenue Market Share by Company in 2021
Figure 24. Europe Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2028)
Figure 25. Europe Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2028)
Figure 26. Europe Cyclooxygenase 2 Inhibitor Revenue Share by Country (2017-2028)
Figure 27. Germany Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 28. France Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Cyclooxygenase 2 Inhibitor Revenue Share by Region (2017-2028)
Figure 36. China Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 39. India Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 41. Taiwan Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 45. Philippines Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 46. Vietnam Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Cyclooxygenase 2 Inhibitor Revenue Market Share by Company in 2021
Figure 48. Latin America Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Cyclooxygenase 2 Inhibitor Revenue Share by Country (2017-2028)
Figure 51. Mexico Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Cyclooxygenase 2 Inhibitor Revenue Share by Country (2017-2028)
Figure 58. Turkey Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 60. UAE Cyclooxygenase 2 Inhibitor Revenue (2017-2028) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 62. Bayer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 65. Sabinsa Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 66. Cadila Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 67. Mylan Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 68. Teva Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 69. Alembic Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 70. Aurobindo Pharma Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 71. Cipla Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 72. Torrent Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
  • Global Polyp Traps Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 102
    Highlights The global Polyp Traps market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Polyp Traps is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia-Pacifi......
  • Global Polypectomy Snares Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 118
    A polypectomy snare is a wire loop device used during colonoscopy designed to slip over a polyp and, on closure, results in cutting the polyp off at its stalk. Highlights The global Polypectomy Snares market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market ......
  • Global Laparoscopic Retractors Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 96
    Highlights The global Laparoscopic Retractors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Laparoscopic Retractors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through ......
  • Global Laparoscopic Ports Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 88
    Laparoscopic surgery uses several 0.5-1cm incisions. Each incision is called a "port." At each port a tubular instrument known as a trochar is inserted. Specialized instruments and a special camera known as a laparoscope are passed through the trochars during the procedure. Highlights The global Laparoscopic Ports market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of CO......
  • Global Non-contact Infrared Thermometer Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 112
    An infrared thermometer is a thermometer which infers temperature from a portion of the thermal radiation sometimes called black-body radiation emitted by the object being measured. Highlights The global Non-contact Infrared Thermometer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market ......
  • Global Hemostatic & Tissue Sealants Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 107
    Hemostatic agents and tissue sealants are used routinely to prevent excess blood loss and in reconstruction during surgical repair. Some of the available products include thrombin sealant, fibrin glue, bovine serum/albumin/glutaraldehyde, and gelatin matrix. Highlights The global Hemostatic & Tissue Sealants market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19......
  • Global Emergency Medical Service (EMS) Products Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 108
    Emergency medical services involve acute care of patients. EMS department manages patients with medical, obstetric, and surgical emergencies. The department is also equipped to treat injuries, infections, heart attacks, strokes, asthma, and acute pregnancy complications. For instance, U.S. has hospital- as well as non-hospital-based emergency departments. Highlights The global Emergency Medical Service (EMS) Products market was valued at US$ 7666.2 million in 2022 and is anticipate......
  • Global Organic Iodide Contrast Agents Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure. Highlights The global Organic Iodide Contrast Agents market was valued at US$ million in 2022 and is anticipated to rea......
  • Global Iodine Formulations Contrast Agents Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 94
    Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure. Highlights The global Iodine Formulations Contrast Agents market was valued at US$ million in 2022 and is anticipated t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs